Published in Clin Gastroenterol Hepatol on December 17, 2010
Helicobacter pylori protein-specific antibodies and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (2013) 2.01
Accuracy and cut-off values of pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy: influence of gastritis. PLoS One (2011) 0.97
Follow-up testing after treatment of Helicobacter pylori infections: cautions, caveats, and recommendations. Clin Gastroenterol Hepatol (2010) 0.86
A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication. PLoS One (2017) 0.75
Management of Helicobacter pylori Infection: What Should the Surgeon Know? Visc Med (2017) 0.75
Errors in laboratory medicine. Clin Chem (2002) 4.87
MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol (2009) 3.29
Errors in a stat laboratory: types and frequencies 10 years later. Clin Chem (2007) 3.23
Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. Am J Gastroenterol (2009) 3.18
The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut (2007) 3.15
Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer (2006) 2.89
Design and methodologies of the POSTconditioning during coronary angioplasty in acute myocardial infarction (POST-AMI) trial. Cardiology (2010) 2.88
A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology (2004) 2.70
Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology (2012) 2.68
Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell (2005) 2.66
Clinical relevance of Helicobacter pylori cagA and vacA gene polymorphisms. Gastroenterology (2008) 2.63
Stepwise combination algorithms of non-invasive markers to diagnose significant fibrosis in chronic hepatitis C. J Hepatol (2006) 2.61
Vitamin D and musculoskeletal health, cardiovascular disease, autoimmunity and cancer: Recommendations for clinical practice. Autoimmun Rev (2010) 2.38
Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol (2008) 2.32
Genetic susceptibility to nonsteroidal anti-inflammatory drug-related gastroduodenal bleeding: role of cytochrome P450 2C9 polymorphisms. Gastroenterology (2007) 2.32
Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int J Cardiol (2012) 2.28
HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Th1 response. Cancer Immunol Immunother (2011) 2.16
Glaucoma and Helicobacter pylori: eyes wide shut? Dig Liver Dis (2012) 2.10
Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma. Clin Gastroenterol Hepatol (2009) 2.09
Preanalytical quality improvement: from dream to reality. Clin Chem Lab Med (2011) 2.01
How to use high-sensitivity cardiac troponins in acute cardiac care. Eur Heart J (2012) 2.00
Susceptibility of Helicobacter pylori to metronidazole. Am J Gastroenterol (2003) 1.98
Identifying risk in the use of tumor markers to improve patient safety. Clin Chem Lab Med (2016) 1.91
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis. Nat Genet (2006) 1.90
Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg (2004) 1.88
Recommendations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J (2010) 1.88
Caustic injury of the upper gastrointestinal tract: a comprehensive review. World J Gastroenterol (2013) 1.86
Preanalytical variability: the dark side of the moon in laboratory testing. Clin Chem Lab Med (2006) 1.85
What's next in translational medicine? Clin Sci (Lond) (2007) 1.85
Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study. Eur Heart J (2005) 1.80
Myths and misconceptions about chronic constipation. Am J Gastroenterol (2005) 1.78
Global eradication rates for Helicobacter pylori infection: systematic review and meta-analysis of sequential therapy. BMJ (2013) 1.74
Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol (2011) 1.67
Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Stroke (2010) 1.67
Liver biopsy sampling in chronic viral hepatitis. Semin Liver Dis (2004) 1.66
Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome. Cytokine (2004) 1.65
Biochemistry and clinical role of human cystatin C. Crit Rev Clin Lab Sci (2004) 1.65
The prevalence of diarrhea and its association with drug use in elderly outpatients: a multicenter study. Am J Gastroenterol (2008) 1.64
Effects of sample transportation on commonly requested laboratory tests. Clin Chem Lab Med (2012) 1.64
Acute-phase markers of inflammation and glomerular structure in patients with type 2 diabetes. J Am Soc Nephrol (2005) 1.63
Connections between genetics and clinical data: Role of MCP-1, CFTR, and SPINK-1 in the setting of acute, acute recurrent, and chronic pancreatitis. Am J Gastroenterol (2009) 1.63
Prediction of lymph node status in superficial esophageal carcinoma. Ann Surg Oncol (2008) 1.62
Cystatin C is a more sensitive marker than creatinine for the estimation of GFR in type 2 diabetic patients. Kidney Int (2002) 1.61
Automated blood cell counts: state of the art. Am J Clin Pathol (2008) 1.59
Hemolyzed specimens: a major challenge for emergency departments and clinical laboratories. Crit Rev Clin Lab Sci (2011) 1.56
Accreditation of medical laboratories in the European Union. Clin Chem Lab Med (2007) 1.55
Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst (2006) 1.55
Laboratory medicine does matter in science (and medicine)… yet many seem to ignore it. Clin Chem Lab Med (2015) 1.53
Preanalytical quality improvement: in quality we trust. Clin Chem Lab Med (2013) 1.52
Barrett's epithelium after antireflux surgery. J Gastrointest Surg (2005) 1.52
Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig Dis Sci (2004) 1.51
Helicobacter pylori-negative gastritis: prevalence and risk factors. Am J Gastroenterol (2012) 1.51
Clinical usefulness of gastric-juice analysis in 2007: the stone that the builders rejected has become the cornerstone. Gastrointest Endosc (2007) 1.51
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Clin Chim Acta (2012) 1.51
Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas (2006) 1.50
Barrett's esophagus and adenocarcinoma risk: the experience of the North-Eastern Italian Registry (EBRA). Ann Surg (2012) 1.50
An appeal to medical journal editors: the need for a full description of laboratory methods and specimen handling in clinical study reports. Transfusion (2012) 1.50
Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med (2008) 1.50
Shop for quality or quantity? Volumes and costs in clinical laboratories. Clin Chem Lab Med (2013) 1.50
Definition of Barrett's esophagus dysplasia: are we speaking the same language? World J Surg (2015) 1.50
Copeptin (CTproAVP), a new tool for understanding the role of vasopressin in pathophysiology. Clin Chem Lab Med (2014) 1.49
Ultrasound, anthropometry and bioimpedance: a comparison in predicting fat deposition in non-alcoholic fatty liver disease. Eat Weight Disord (2014) 1.48
The syndrome of the "obsessive-compulsory scientist": a new mental disorder? Clin Chem Lab Med (2013) 1.47
Protein turnover, lipolysis, and endogenous hormonal secretion in critically ill children. Crit Care Med (2002) 1.47
Liver steatosis in children with chronic hepatitis C. Am J Gastroenterol (2006) 1.46
Use of lactoferrin for Helicobacter pylori eradication. Preliminary results. J Clin Gastroenterol (2003) 1.45
Quality Indicators in Laboratory Medicine: from theory to practice. Preliminary data from the IFCC Working Group Project "Laboratory Errors and Patient Safety". Clin Chem Lab Med (2011) 1.44
Helicobacter pylori and pancreatic disease. JOP (2003) 1.43
Anti-Helicobacter pylori antibodies in cervical mucus: a new cause of infertility. Eur J Obstet Gynecol Reprod Biol (2010) 1.43
Prevalence and Clinical Relevance of IgE Sensitization to Profilin in Childhood: A Multicenter Study. Int Arch Allergy Immunol (2015) 1.42
Long-term treatment with mesalazine in patients with symptomatic uncomplicated diverticular disease. Intern Emerg Med (2011) 1.42
Effect of maternal smoking on breast milk interleukin-1alpha, beta-endorphin, and leptin concentrations and leptin concentrations. Environ Health Perspect (2005) 1.42
CCLM: evolving to meet the needs of today's laboratory professionals and scientists. Clin Chem Lab Med (2008) 1.42
Recommendations for the use of natriuretic peptides in acute cardiac care: a position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care. Eur Heart J (2011) 1.42
Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol (2012) 1.41
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Helicobacter pylori eradication: are we really all equal? A controlled study in native and immigrant population. Intern Emerg Med (2010) 1.40
Is laboratory medicine a dying profession? Blessed are those who have not seen and yet have believed. Clin Biochem (2010) 1.40
Reduction of unsuitable specimens: a more radical and comprehensive approach is needed. Clin Chim Acta (2010) 1.39
Preanalytical quality improvement. In pursuit of harmony, on behalf of European Federation for Clinical Chemistry and Laboratory Medicine (EFLM) Working group for Preanalytical Phase (WG-PRE). Clin Chem Lab Med (2015) 1.39
What is behind the presence of anti-neutrophil cytoplasmatic antibodies in chronic liver disease? Liver Int (2009) 1.39